Atlas Trials

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Clinical trial NCT00905632 · COMPLETED

Trial details

NCT number
NCT00905632
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2009-05-01
Primary completion
2011-03-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.